Abstract
Non-tumoral portions of kidneys obtained from two b1 chain and the laminin c1 chain. At the S-shape patients undergoing a nephrectomy for renal cell carcinoma body stage, molecules containing the laminin a5 chain were used as controls. In both cases, no glomerular lesion start to accumulate, while those including either the could be detected by light microscopy or by immunolaminin a1 chain or the laminin a4 chain progressively fluorescence. disappear. At the capillary loop stage, molecules containing the laminin b1 chain are progressively replaced by ones containing the laminin b2 chain. At or after Antibodies the capillary loop stage, molecules including the Monoclonal antibodies recognizing the NC1 domain of the a3(IV ), a4(IV ) and a5( IV ) collagen chains appear a1(IV ) collagen chain (MAB1), of the a3(IV ) collagen chain and progressively become the very prominent colla-(MAB3) and of the a5(IV ) collagen chain (MAB5), respectgenous components of the GBM. Parallel to these ively, were obtained from Wieslab (Lund, Sweden). A monochanges, fibronectin progressively disappears from clonal antibody directed against the laminin b2 chain (C4) the GBM.
was obtained from Developmental Studies Hybridoma Bank Proteinuria associated with glomerular diseases is (Iowa City, IA). A monoclonal antibody against the secondary to alterations of the charge-selective and/or laminin b1 chain (4E10) was purchased from GIBCO size-selective properties of the GBM, but molecular Life Technologies (Rockville, MD). A monoclonal antimodifications that are responsible for these functional fibronectin antibody was obtained from Biohit (Bonnelles, France). A monoclonal anti-vimentin antibody ( VIM-13.2) changes are still poorly understood [7] . Animal studies was obtained from Sigma (St Louis, MO). A monoclonal have suggested that the sieving properties of the GBM antibody directed against synaptopodin (G1D4) was depend on its precise composition in laminin isoforms. When a null mutation is introduced in the gene coding Finally, an affinity purified fluorescein isothiocyanate (FITC ) for the laminin b2 chain, knockout mice develop heavy conjugated goat antibody specific for mouse IgG was purproteinuria immediately after birth [8] . One week after chased from Biosys ( Karben, Germany). birth, the GBM of these animals appears to be structurally normal, as judged by light and electron microImmunohistochemistry scopy, and the only modifications that have been detected at this time are the presence of laminin Cryostat serial sections (2.5 mm) were air-dried, fixed in molecules containing the b1 chain [8] . These experiacetone for 3 min, washed once in phosphate-buffered saline mental results prompted us to study whether primary (PBS) pH 7.4, and incubated in a moist chamber with the glomerulonephritides responsible for heavy proteinuria appropriate dilution of primary antibodies (MAB1 1550, were associated with modifications of laminin isoforms MAB3 1550, MAB5 1550, 4E10 1520, C4 15100, VIM-13.2 present within the GBM.
15150, G1D4 151). Before adding MAB5, sections were denatured by incubation for 5 min in a solution containing 0.1 M glycine and 6 M urea, and rinsed once with distilled water. After 2 h of incubation, slides were washed three times in PBS and incubated with the FITC secondary antibody for
Subjects and Methods
30 min in a moist chamber. They were then rinsed three times in PBS and mounted using 0.5 M Tris-HCl pH 8.0,
Patients and renal biopsies
50% glycerol. Labelling was examined using a Zeiss Axiophot 2 microscope. In each case, a control staining was done by Immunohistochemical studies of kidney biopsies were per-omitting the first antibody. For 4E10, staining of the GBM formed in 20 patients with heavy proteinuria who underwent was scored semi-quantitatively, using a 0 to +++ scale, by a renal biopsy within the last 3 years, in addition to routine an investigator unaware of the diagnosis. diagnostic examination (Table 1) . Ten patients had membranous glomerulonephritis (MGN ), five had focal and segmental glomerulosclerosis (FGS ), and five had minimal Results change disease (MCD). All patients had proteinuria of at least 2.0 g/day (mean±SD: 4.7±2.7 g/day; range: 2-11 g/day), associated with serum albumin of <30 g/l. Patients with minimal change disease and control Serum creatinine was in the normal range (mean±SD: biopsies 76±16 mmol/l; range: 50-100 mmol/l ), except for one patient An identical staining pattern was observed for all five with MGN (serum creatinine: 150 mmol/l ) and three patients with FSG (serum creatinine: 140, 160 and 180 mmol/l, respect-patients with MCD ( Figure 1 ) and for the two control ively). All glomerulopathies were considered as idiopathic, biopsies (data not shown), using the three anti-collagen and in particular no patient had anti-nuclear antibodies, IV antibodies and the two anti-laminin antibodies.
HIV infection, viral hepatitis or was taking a drug known MAB1 strongly stained all renal basement memto induce MGN. No patient had received immunosuppressive branes, with the exception of the GBM which was drugs before renal biopsy, except two patients with MCD weakly stained ( Figure 1A ), and it also stained the who had been treated with corticosteroids for 1 and 3 mesangium ( Figure 1A ). MAB3 diffusely stained the months, respectively, at the time of biopsy.
GBM and the basement membrane of distal tubules,
The expression of the laminin b1 and b2 chains was also while it gave an occasional focal staining of the studied in kidney biopsies from three patients with mesangiBowmans' capsule ( Figure 1B) . MAB5 stained the ocapillary glomerulonephritis (MCGN ), and from three patients with IgA nephropathy (IgAN ).
GBM, the Bowman's capsule, the basement membrane of distal tubules and collecting ducts ( Figure 1C ). was exactly similar to the one observed in controls 4E10 stained all tubular basement membranes and the ( Figure 3F ) . Surprisingly, in glomeruli, 4E10 stained Bowman's capsule, but there was no staining of the the mesangium but also segments of the external part GBM ( Figure 1D ). In addition, it faintly stained the of the GBM ( Figure 3E , G and H ), and this staining mesangium ( Figure 1D ). C4 only stained the GBM of the GBM could be detected in all glomeruli for all and the basement membranes of arterial smooth 10 patients. The staining pattern was mostly granular muscles ( Figure 1E ). In control biopsies, anti-( Figure 3G and H ), but some segments of the GBM fibronectin antibody showed the same staining pattern showed a linear labelling ( Figure 3E and G). The as MAB1 (data not shown). percentage of capillary loops showing such a staining pattern was quite similar when different glomeruli from a given biopsy were compared, but it was highly Patients with focal and segmental glomerulosclerosis variable between one patient and another ( Table 2) . In biopsies from all five patients with FGS, the staining An identical staining pattern was observed when the pattern observed with MAB3, MAB5 and 4E10 was reaction was performed in the presence of 5% normal the same as the one observed in normal kidneys human serum, confirming that 4E10 did not cross-( Figure 2C-E) . In glomeruli, MAB1 ( Figure 2A and react with human IgG (data not shown). No labelling B) and C4 ( Figure 2F ) stained the same structures as was detected when 4E10 was omitted in the first in normal kidneys but, in addition, MAB1 stained incubation step (data not shown). No clear correlation segmental areas corresponding to sclerotic lesions could be established between the intensity of the stain-( Figure 2B ), and C4 stained segmental areas of the ing and the levels of proteinuria (compare data from Bowman's capsule ( Figure 2F ). In all three biopsies Table 1 with Table 2 ). The anti-fibronectin antibody with interstitial fibrosis, some focal staining of inter-stained the mesangium, but a patchy staining of the stitial fibrotic areas was also detected with MAB1 GBM could also be detected in all four patients tested ( Figure 2B) .
(data not shown).
The presence of embryonic isoforms of laminin Patients with membranous glomerulopathy
within the GBM prompted us to study the expression of two proteins that are normally synthesized at or All the structures that were stained with MAB1, MAB3 after the pre-capillary loop stage: vimentin and synapand MAB5 in control biopsies were also stained in topodin. Kidney biopsies from seven patients with biopsies from patients with MGN ( Figure 3A-D) . In MGN were stained using VIM-13.2 and G1D4. In all addition, in all seven stage II MGN (patients 1, 3, 4, seven cases, G1D4 stained the podocytes, and 5, 7, 9 and 10), a clear staining of spikes was detected VIM-13.2 stained the podocytes as well as the using MAB3 (data not shown) and MAB5 ( Figure 3C ). The staining pattern observed with C4 endothelial cells ( Figure 4) . 
Patients with mesangiocapillary glomerulonephritis and

Discussion
IgA glomerulopathy
In this study, we used indirect immunofluorescence to To confirm that the GBM staining observed using compare the composition of the GBM in normal 4E10 in biopsies from patients with MGN was not due kidneys and in renal biopsies from patients with various to the presence of immune deposits along the GBM, primary glomerulonephritides associated with heavy kidney biopsies from three patients with MCGN were proteinuria. Five MCD, five FSG and 10 MGN were stained using 4E10 and C4. In all three cases, 4E10 studied. stained the tubular basement membranes, the Our findings concerning the distribution of the Bowman's capsule and the mesangium but it did not a1(IV ), a3(IV ) and a5(IV ) collagen chains, the lamistain the GBM (Figure 5 ). In contrast, the GBM was nin b1 chain, the laminin b2 chain and fibronectin in labelled by C4 (data not shown). Identical results were normal glomeruli are in agreement with previous observed with kidney biopsies from three patients with IgAN ( Figure 5 and data not shown) .
reports [9] [10] [11] . Our data confirm that the GBM con- Fig. 2 . Immunofluorescence of kidney sections from patients with FSG. Sections were stained with antibodies to collagen a1(IV ) (A and B), collagen a3(IV ) (C ), collagen a5(IV ) (D), laminin b1 (E ) and laminin b2 (F ). The newly formed matrix reacted with anti-a1(IV ) (B, arrow), and segmental areas of the Bowman's capsule were stained with anti-laminin b2 ( F ). The staining pattern was otherwise identical to the one observed in patients with MCD (compare with Figure 1) . Magnification, ×250.
tains large amounts of a3(IV ) and a5(IV ) collagen results obtained using antibodies recognizing different type IV collagen chains are consistent with earlier chains, and little a1(IV ) collagen chain. They also confirm that laminin molecules present within the reports [11] [12] [13] [14] [15] [16] . Previous studies have shown that the collagen composition of newly formed matrix varies GBM contain the laminin b2 chain, but not the laminin b1 chain. Finally, they show that the GBM does not depending on the glomerulopathy, and that in MGN the spikes contain the a3(IV ), a4(IV ) and a5(IV ) contain fibronectin.
In renal biopsies from patients with proteinuria, collagen chains [11] [12] [13] [14] 16 ] , while in FGS the matrix anti-a3(IV ) and anti-a5(IV ) antibodies. The unexpected finding of our study is that in MGN tended to be older than the ones with FSG or MCD, but the presence of laminin b1 within the GBM is most likely not age related, since it was observed in that accumulates between podocytes and the GBM is all patients with MGN, including two patients who composed of a1/a2( IV ) collagen chains [11, 15] . In were below 30 years of age, and three patients between biopsies from patients with MGN or MCD incubated 30 and 50 years-old. Several groups have shown that with the anti-a1(IV ) antibody, staining of the GBM laminin is present in the newly formed matrix in seemed to be restricted to the endothelial side, while patients with 16, 17] and that there is an in biopsies from patients with FGS the anti-a1(IV ) collagen antibody stained the newly formed matrix. In increased production of laminin in a rat model of 
